Effects of acute intravenous iloprost on right ventricular hemodynamics in rats with chronic pulmonary hypertension

• Published in: Pulmonary circulation Vol. 4; no. 4; pp. 612 - 618
• Main Authors: Zeineh, Nabil S., Bachman, Timothy N., El-Haddad, Hazim, Champion, Hunter C.
• Format: Journal Article
• Language: English
• Published: London, England University of Chicago Press 01.12.2014; SAGE Publications; John Wiley & Sons, Inc
• Subjects: Animal models; Cardiac output determination; contractility; Dose response relationship; Heart rate; Hemodynamics; Myocardium; Original Research; prostacyclin; Pulmonary arteries; Pulmonary hypertension; Rats; Recreational vehicles; right ventricle; Rodents; Vascular resistance; right ventricle; prostacyclin; contractility
• ISSN: 2045-8932; 2045-8940; 2045-8940
• DOI: 10.1086/677358

The inotropic effects of prostacyclins in chronic pulmonary arterial hypertension (PAH) are unclear and may be important in directing patient management in the acute setting. We sought to study the effects of an acute intravenous (IV) infusion of iloprost on right ventricular (RV) contractility in a rat model of chronic PAH. Rats were treated with monocrotaline, 60 mg/kg intraperitoneally, to induce PAH. Six weeks later, baseline hemodynamic assessment was performed with pressure-volume and Doppler flow measurements. In one group of animals, measurements were repeated 10–15 minutes after IV infusion of a fixed dose of iloprost (20 μg/kg). A separate group of rats underwent dose-response assessment. RV contractility and RV–pulmonary artery coupling were assessed by the end-systolic pressure-volume relationship (ESPVR) and end-systolic elastance/effective arterial elastance (Ees/Ea). RV cardiomyocytes were isolated, and intracellular cAMP (cyclic adenosine monophosphate) concentration was measured with a cAMP-specific enzyme immunoassay kit. Animals had evidence of PAH and RV hypertrophy. Right ventricle/(left ventricle + septum) weight was 0.40 ± 0.03. RV systolic pressure (RVSP) was 39.83 ± 1.62 mmHg. Administration of iloprost demonstrated an increase in the slope of the ESPVR from 0.29 ± 0.02 to 0.42 ± 0.05 (P < .05). Ees/Ea increased from 0.63 ± 0.07 to 0.82 ± 0.06 (P < .05). The RV contractility index (max dP/dt normalized for instantaneous pressure) increased from 94.11 to 114.5/s (P < .05), as did the RV ejection fraction, from 48.0% to 52.5% (P < .05). This study suggests a positive inotropic effect of iloprost on a rat model of chronic PAH.